fenoldopam and ioversol

fenoldopam has been researched along with ioversol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Duffy, ME; Kamran, M; Kim, M; Kini, AS; Marmur, JD; Mitre, CA; Sharma, SK; Suleman, J	1
Bjarnason, H; Chamsuddin, AA; Dietz, CA; Gomes, MD; Hunter, DW; Kowalik, KJ; McDermott, CM; Rosenberg, MS	1

Reviews

1 review(s) available for fenoldopam and ioversol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for fenoldopam and ioversol

Article	Year
Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. The American journal of cardiology, 2002, Apr-15, Volume: 89, Issue:8 Topics: Aged; Atherectomy, Coronary; Cardiac Catheterization; Contrast Media; Diabetic Nephropathies; Dopamine Agonists; Female; Fenoldopam; Humans; Incidence; Kidney Diseases; Kidney Failure, Chronic; Male; Risk Factors; Stents; Triiodobenzoic Acids	2002
Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy. AJR. American journal of roentgenology, 2002, Volume: 179, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Dopamine Agonists; Female; Fenoldopam; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Renal Circulation; Retrospective Studies; Risk Assessment; Triiodobenzoic Acids	2002

Article

Year

Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam.

The American journal of cardiology, 2002, Apr-15, Volume: 89, Issue:8

Topics: Aged; Atherectomy, Coronary; Cardiac Catheterization; Contrast Media; Diabetic Nephropathies; Dopamine Agonists; Female; Fenoldopam; Humans; Incidence; Kidney Diseases; Kidney Failure, Chronic; Male; Risk Factors; Stents; Triiodobenzoic Acids

2002

Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy.

AJR. American journal of roentgenology, 2002, Volume: 179, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Dopamine Agonists; Female; Fenoldopam; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Renal Circulation; Retrospective Studies; Risk Assessment; Triiodobenzoic Acids

2002